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Abstract
Reports on structural diversification of steroids by means of multicomponent reactions (MCRs) have significantly increased over
the last decade. This review covers the most relevant strategies dealing with the use of steroidal substrates in MCRs, including the
synthesis of steroidal heterocycles and macrocycles as well as the conjugation of steroids to amino acids, peptides and carbo-
hydrates. We demonstrate that steroids are available with almost all types of MCR reactive functionalities, e.g., carbonyl,
carboxylic acid, alkyne, amine, isocyanide, boronic acid, etc., and that steroids are suitable starting materials for relevant MCRs
such as those based on imine and isocyanide. The focus is mainly posed on proving the amenability of MCRs for the diversity-
oriented derivatization of naturally occurring steroids and the construction of complex steroid-based platforms for drug discovery,
chemical biology and supramolecular chemistry applications.
Review
1 Introduction
The utilization of multicomponent reactions (MCRs) [1] for the
derivatization of biomolecules has continuously grown over the
last years. These diversity-oriented and complexity-generating
processes [2,3] have proven success in peptide ligation [4] and
macrocyclization [5,6], protein glycoconjugation [7], lipidation
of peptides [8] and glycosides [9], and carbohydrate modifica-
tion [10]. A special class of lipidic biomolecules are the
steroids, which can be either totally lipophilic (e.g., cholesterol)
or amphipathic when possessing both polar and nonpolar groups
(e.g., cholic acid). As shown in Figure 1, members of this
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Figure 1: Structures of natural steroids of A) animal and B) plant origin.
family can be found in both plant and animal kingdoms, where
they exert an amazing array of cellular functions such as struc-
tural and hormonal ones. All steroids are based on a common
skeleton containing three fused six-membered rings and one
five membered ring. This fused-ring system provides a readily
available source of rigidity and chirality, whose substituents can
be oriented either towards the α- or the β-face. Steroids feature
a polyprenyl nature, which is particularly evident in the side
chain, and have additional structural elements such as the
methyl groups at positions 10 and 13, always β-oriented. Other
positions of the steroidal nucleus of frequent natural functionali-
zation are C-3 (usually bearing a hydroxy group) and C-17, this
latter holding the aliphatic side chain but also often having
oxygenated functions [11]. Similarly, rings B and C can be
naturally functionalized with a varied set of groups including
hydroxy, carbonyl and olefins, which along with those present
in rings A and D and the side chain are the basis of steroid
biological functions. Such oxygenated and alkene groups
represent the entrance door for subsequent synthetic modifica-
tions, including the incorporation of MCR reactive functionali-
ties.
In the last two decades, MCRs have emerged as effective tools
for the rapid derivatization of steroidal skeletons in the pursuit
of medicinal and supramolecular chemistry applications.
Despite some review articles have described selected examples
of MCRs used to modify and to macrocyclize steroidal com-
pounds [12,13], to our knowledge there is no review exclusive-
ly dedicated to covering the applications of MCRs with steroids.
Herein, we provide a comprehensive review describing – to our
understanding – the most important inputs of the utilization of
MCRs in the structural diversification of steroids. The review is
divided in different aspects of steroid chemistry, such as modifi-
cation of the side chain and the steroidal nucleus, the assembly
of nitrogen-heterocycles fused to the steroid-ring system, the
steroid conjugation and macrocyclization, all relying on MCRs.
2 Modification of the steroidal nucleus and
the side chain
2.1 Isocyanide-based MCRs
2.1.1 Steroids as carbonyl component: One of the first steroid
derivatization methods using MCRs was reported by the Ugi
laboratory in 1995 (Scheme 1) [14]. The occurrence of pachys-
termin A, an unusual natural steroid isolated from the boxac-
eous plant Pachysandra terminalis and having a β-lactam
moiety in ring A, inspired these authors to obtain a steroidal
β-lactam, albeit functionalized in the side chain. The one-pot
synthesis of the β-lactam steroid was achieved via the Ugi
3-component-4-center reaction using the dehydrocholic alde-
hyde 1 as carbonyl component. This variation of the Ugi reac-
tion including a β-amino acid component allows the formation
of the 4-membered ring of the β-lactam moiety, which is diffi-
cult to obtain through other traditional methods like the cycliza-
tion of acyclic precursors because of both the Baeyer strain of
the newly formed ring and conformational effects [15]. Howev-
er, the readily formation of the 4-membered ring by this MCR is
due to the ring contraction of the 7-membered ring cyclic inter-
mediate by transannular acyl transfer, which leads to the
β-lactam derivative. Despite the chiral nature of the steroidal
substrate, no significant stereoselective induction was observed,
probably because the 7-membered ring intermediate was far
away from the chiral steroidal nucleus.
Beilstein J. Org. Chem. 2019, 15, 1236–1256.
1238
Scheme 1: Synthesis of a steroidal β-lactam by Ugi reaction of a cholanic aldehyde [14].
Scheme 2: Synthetic route to steroidal 2,5-diketopiperazines based on a diastereoselective Ugi-4CR with an androstanic aldehyde derived from
dehydroepiandrosterone (DHEA) [16].
A better stereoselectivity was reported by Bruttomesso et al. in
their work on the Ugi four-component reaction (Ugi-4CR) with
a steroidal aldehyde, in which the carbonyl group was directly
linked at the steroidal framework [16]. As shown in Scheme 2,
the authors found a high diastereoselectivity in the Ugi-4CR
conducted with a carbonyl linked at C-17, a sterically crowed
position very close to the axial methyl group placed of C-13.
This step was implemented as part of the synthetic route toward
steroidal 2,5-diketopiperazine 6, based on a strategy previously
proposed by Marcaccini and co-workers [17]. Here, the route
included the Ugi-4CR reaction of varied amines and
isocyanides with the androstanic aldehyde 4 and chloroacetic
acid followed by a post-cyclization reaction by treating the Ugi
products 5 with ethanolic KOH under ultrasonication. This
protocol provided a small library of steroidal 2,5-diketopiper-
azines 6 obtained as a single diastereomer, thus proving the
high diastereoselection of the initial Ugi-4CR with the steroidal
carbonyl substrate. In the 2,5-diketopiperazine ring, the config-
uration of the new asymmetric center C-3’ was S, a result con-
firmed by NOESY experiments.
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Scheme 3: Multicomponent synthesis of a heterocycle–steroid hybrid using a ketosteroid as carbonyl component [18].
In comparison with the work described above, it can be sug-
gested that in the case of the 2,5-diketopiperazine synthesis, the
distance of the carbonyl moiety to the steroidal nucleus is deter-
minant for the diastereoselection of the Ugi-type reaction. Thus,
when the carbonyl is far away from the rigid chiral steroid, the
Ugi reaction shows no significant diastereoselectivity, while the
carbonyl component directly linked to the bulky steroidal
nucleus – especially in α-position of a stereocenter – provides a
very good diastereocontrol in the MCR.
Dar et al. [18] reported another example of a diastereoselective
MCR between a 6-ketosteroid, 2-aminopyridines and an
isocyanide, using propylphosphonic acid anhydride (TP3) as
catalyst to afford a steroidal derivative with an imidazole-pyri-
dine moiety attached to ring B. This moiety is present in several
compounds displaying biological activities such as antimicrobi-
al, antiviral and anti-inflammatory, among others. Scheme 3
exemplifies the reaction of cholestan-6-one 7 with 2-aminopyri-
dine and phenyl isocyanide to afford the heterocycle–steroid
hybrid 8 in good yield and diastereoselectivity, whereas differ-
ent ketosteroids could be used as starting materials, thus
proving the versatility of this reaction. Also, this group extend-
ed the reaction scope to different 2-aminopyridines with elec-
tron-donating groups in para and meta positions, and to benzyl
and other alkyl isocyanides. The proposed mechanism follows
the first step of the Ugi-4CR reaction, i.e., the formation of the
imine between the ketosteroid and the amine group of the
aminopyridine derivative. Then, the imine suffers the nucleo-
philic attack of the isocyanide generating a nitrilium intermedi-
ate. Differently from the Ugi-4CR, the final step is the cycliza-
tion between the pyridine N atom and the isocyanide. TP3 plays
the catalytic role by acidic activation of the ketone to favor the
imine formation.
2.1.2 Steroids as amine and carboxylic acid components:
Several groups have employed steroidal substrates as amino and
carboxylic acid components of the Ugi-4CR, which is indeed
one of the MCRs of major incidence in the field of steroid
chemistry. Rivera and co-workers were the first to employ this
4CR for the conjugation of amino acids to steroids [19] as
part of a general program for the synthesis of peptido-
mimetic–steroid hybrids [20,21]. As shown in Scheme 4, the
authors developed methods for the functionalization of
spirostanic steroids and their further conjugation to amino acids
by means of the Ugi-4CR. Thus, seco-steroidal amine 10 –
derived from the steroidal sapogenin hecogenin (9) – was
ligated to Boc-protected serine in presence of paraformalde-
hyde and benzyl isocyanide to form hybrid 11 in good yield.
Similarly, the spirostanic lactone 12 was transformed into
spirostanic acid 13 and amine 14, which were next ligated to
alanine methyl ester and Boc-histidine leading to the amino
acid–steroid conjugates 15 and 16, respectively. This approach
was also employed for the ligation of amino acids to spirostanic
seco-steroids at ring B and for the simultaneous incorporation
of two amino acid residues [19].
Ramírez and co-workers have extended the application of the
Ugi-4CR to the diversity-oriented functionalization of
androstanic and preganinc steroids using a carboxylic acid
group at the side chain [22,23]. As shown in Scheme 5, the
implementation of the Ugi-4CR with a variety of amines and
isocyanides – keeping formaldehyde as the oxocomponent –
enabled the generation of azasteroid libraries based on
androstanic (18) and pregnanic (19) skeletons. These aza-
steroids, in which one or more nitrogen atoms are present in the
side chain, were designed as promising compounds since such
classes of antifungal steroids were known in the literature.
Some of the resulting azasteroids showed inhibitory effects on
the growth of fungi such Fusarium lateritium (causal agent of
chlorotic leaf distortion in sweet potato) and Fusarium virguli-
forme (causal agent of sudden death syndrome in soy bean),
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Scheme 4: Synthesis of peptidomimetic–steroid hybrids using the Ugi-4CR with spirostanic amines and carboxylic acids [19].
Scheme 5: Synthesis of azasteroids using the Ugi-4CR with androstanic and pregnanic carboxylic acids [22].
without exerting in vitro toxicity on mammalian cells. Another
interesting result came out from the comparison of the biologi-
cal activity between homologous pairs 18 and 19 [22]. For ex-
ample, the pair of androstanic and pregnanic derivatives incor-
porating R1 = Phe and R2 = t-Bu showed significant activity
against both fungi tested, but the compounds derived from
Beilstein J. Org. Chem. 2019, 15, 1236–1256.
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Figure 2: Ugi-4CR-derived library of androstanic azasteroids with diverse substitution patterns at the phenyl ring (amine component) [23].
benzylamine (i.e., R1 = Bn) did exhibit either a low or null bio-
logical activity for the fungi. This could indicate that the anti-
fungal properties of such azasteroids very much depend on the
phenyl moieties attached to the side chain. This type of biologi-
cal comparison could be established because of the versatility of
the synthetic strategy based on the MCR tool.
On the other hand, the family of compound class 18 was evalu-
ated for the inhibition of the viral multiplication and for their
implication in intracellular localization of viral glycoproteins
[23]. Two compounds showed antiviral effects against herpes
simplex virus 1 (HSV-1, KOS strain) and vesicular stomatitis
virus (VSV). The key structural characteristics of both com-
pounds are the presence of a phenyl moiety as R1 and a t-Bu
group at the terminal amide. Thus, using the same synthetic
strategy as shown in Scheme 5, Dávola et al. [23] synthetized a
family of new Ugi reaction-derived androstanic azasteroids with
a much more diverse substitution pattern at the phenyl moiety
(Figure 2A).
The small library of compounds enabled a better understanding
of the structural factors determining the antiviral activity versus
the cytotoxic one, with the major effect found for substituents at
the para-position [23]. Eventually, this work allowed the design
of new compounds with antiviral activity and reduced cyto-
toxic effects by changing the type and position of the substitu-
ent. Such small structural changes could be implemented in a
rapid manner because of the easy setup of the MCR approach.
To get a deeper insight into the biological effect of Ugi-derived
steroids, additional libraries were synthesized by Ramírez,
Barquero and co-workers following the concept of varying the
amine component and using the steroid as carboxylic acid
[24,25]. For example, based on the structure of 4,4-dimethyl-
sterols – compounds that are involved in specific physiological
processes – this group used the Ugi-4CR chemistry [24] for the
subsequent diversification of the androstanic family of aza-
steroids, again focusing on the installation of substituted phenyl
groups (derived from the amine component) that gave such
good results in their previous work [22,23]. The library of
androstanic derivatives 21 (Figure 2B) and their reduced ana-
logues bearing the 3β-hydroxy group were biologically tested
showing antifungal activity against Fusarium virguliforme and
Fusarium solani. The generation of this compound library
suffered from the formation of the Passerini reaction byprod-
ucts – likely due to the poor reactivity of the substituted anilines
as amino components of the Ugi-4CR. Nonetheless, the
Passerini products were also evaluated and provided important
information of the structure–activity relationship [24]. An addi-
tional library was built by performing the Ugi-4CR at a
carboxylic acid placed at C-16 [25], a position never before
derivatized by MCRs as its substitution is less common in
Beilstein J. Org. Chem. 2019, 15, 1236–1256.
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Scheme 6: Synthesis of 4-azacholestanes by an intramolecular Ugi-4C-3R [26].
natural steroids. The authors extended the studies of the C-16
Ugi-derivatized steroids as antiviral agents and found com-
pounds with inhibitory effects against HSV-1 spread (on the
wild type and on the acyclovir-resistant strains), as they inter-
fered with late steps in the viral replication cycle [25].
An interesting feature of the Ugi reactions shown with keto-
steroids having additional carboxylic and aldehyde groups (see
Scheme 1 and Figure 2B) is the lack of side reaction at the ke-
tone functionality. This can be explained by the higher reactivi-
ty of the aldehyde functionalities upon imine formation with
both aliphatic and aromatic amines. However, steroidal ketones
can also participate in Ugi reactions if no additional, more reac-
tive carbonyl components are present. As shown in Scheme 6,
this has been demonstrated by Alonso et. al. [26] with the de-
velopment of a multicomponent approach to obtain 4-aza-
steroids using an intramolecular Ugi-4CR between a bifunc-
tional steroidal ketoacid and different amines and isocyanides.
Because of the poor reactivity of the steroidal ketone, the Ugi-
4CR had to be conducted at reflux to obtain a good yield of
Ugi-derived steroids, albeit the procedure generated a pair of
diastereomers (epimeric at C-5) in almost equal amount. The
stereoselectivity of the intramolecular MCR increased when a
bulky isonitrile was used, e.g., diethyl phosphonate isocyanide.
The configuration of C-5 in each stereoisomer was established
using NOESY experiments and theoretical models.
The main limitation of this approach was the impossibility to in-
corporate both aromatic and sterically hindered amines (e.g.,
tert-butylamine). Besides the reports of Rivera’s and Ramírez’s
groups on Ugi-4CRs with spirostanic, androstanic, pregnanic
and cholestanic carboxylic acids, later on Chowdhury and
co-workers published a similar strategy for the multicomponent
derivatization of cholestanes using microwave assisted Ugi-
4CR [27].
2.1.3 Steroids as the isocyanide component: To our know-
ledge, the first synthesis and application in MCRs of steroidal
isocyanides was reported by Wessjohann and co-workers [28]
during their work on multicomponent macrocyclizations with
steroidal building blocks. After that, this group focused on the
synthesis of steroidal podands using multiple MCRs for the
installation of peptidomimetic chains at different positions of
the steroidal skeleton, which enabled rigidifying the pendant
peptide chains [29]. Scheme 7 depicts two selected examples of
this work, showing the possibility of incorporating isocyanide
groups at furostanic and cholanic steroids and their subsequent
utilization in the Ugi-4CR with monoprotected amino acids
(used either as amino or carboxylic acid components) and form-
aldehyde as fixed oxo component. Amazingly, the Ugi-4CR of
steroidal triisocyanide 26 with three equivalents of Boc-trypto-
phan allowed the formation of twelve covalent bonds in one-
pot, leading to a remarkably complex amino acid–steroid hybrid
27 in very good yield [29].
After the pioneering work of Wessjohann and co-workers, other
groups relied on the functionalization of steroids with
isocyanide groups for their subsequent derivatization by
Beilstein J. Org. Chem. 2019, 15, 1236–1256.
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Scheme 7: Synthesis of amino acid–steroid hybrid by multiple Ugi-4CR using steroidal isocyanides [29].
Scheme 8: Synthesis of ecdysteroid derivatives by Ugi-4CR using a steroidal isocyanide [30].
isocyanide-based MCRs. Thus, Lesma et al. [30] reported an
interesting example of generation of an Ugi product at ring B
using a steroidal isocyanide featuring an insect hormone
ecdysteroid structure. As shown in Scheme 8, a set of Ugi-4CR-
derived ecdysteroids 29 was produced by variation of the amine
and carboxylic acid components, keeping formaldehyde as oxo
component to obtain a single stereoisomer. The library was also
integrated by the Ugi-4CR products derived from the
6β-ecdystereoidal amine (also used as precursor of isocyanide
28), while all compounds were evaluated as antiproliferative
agents against T-leukemia cell line.
A very recent example of a highly diastereoselective Ugi-type
MCR was reported by Rivera, Paixão and co-workers using a
Beilstein J. Org. Chem. 2019, 15, 1236–1256.
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Scheme 9: Stereoselective multicomponent synthesis of a steroid–tetrahydropyridine hybrid using a chiral bifunctional substrate and a cholestanic
isocyanide. DBA: 3,5-dinitrobenzoic acid [31].
steroidal isocyanide [31]. As shown in Scheme 9, the procedure
comprised the organocatalytic asymmetric synthesis of the
chiral bifunctional substrate 30 bearing an masked aldehyde and
an enol functionality, which was subsequently reacted with
isocyanide 31 – derived from cholesterol – and 3,5-
dimethoxyaniline leading to the steroid–tetrahydropyridine
hybrid 32 in good yield and excellent diastereoselectivity. As
previously proven by the authors in their synthetic program on
organocatalytic multicomponent approaches [32] not only the
chiral steroidal isocyanide but also the bifunctional component
30, used in enantiomerically enriched form, plays a crucial role
in the high stereoselection.
The mechanistic insights of this class of MCR were disclosed in
the original publication [31]. In short, the organocatalytic conju-
gated addition of benzoylacetonitrile to cinnamaldehyde gener-
ates the hemiacetal 30, which next initiates the multicomponent
sequence upon condensation with the aniline and formation of
the imine, eventually occurring as a stable cyclic aminal. The
attack of the steroidal isocyanide 31 to the imine (or aminal)
leads to the stereoselective formation of the α-adduct intermedi-
ates, which rearranges to the final tetrahydropyridine ring 32.
Besides the use of steroids as oxo, amine, carboxylic acid and
isocyanide components, there is a very early report by Dumestre
et al. [33] describing the participation of a nitrosteroid and an
acylating agent in a novel isocyanide-based MCR. Thus, the
reaction of a nitrosteroid – derived from 16-dehydropregne-
nalone – with acetic anhydride and tert-butyl isocyanide
furnished an acetyl α-oximinoamide moiety at the steroidal side
chain. Albeit this reaction did not find later synthetic applica-
tions, it encompasses a nice example of the diversity of MCRs
that can be applied to diversify steroidal skeletons.
2.2 Miscellaneous MCRs for steroid derivatization
Despite isocyanide-based MCRs have been the main classes of
multicomponent transformations used in steroid modification,
in the last years various MCRs have emerged as suitable proce-
dures for the diversification of this family of biomolecules. A
remarkable example is the report of Iglesias-Arteaga and
co-workers [34] on the application of the Pd(II)-catalyzed three-
component reaction (3CR) developed by Barluenga et al. [35] to
steroids. The original Barluenga’s 3CR comprises the reaction
of salicylaldehyde with an alkyl orthoformate and 4-pentyn-1-ol
to obtain a 4-alkylchroman spiroketal as a single diastereomer.
However, as shown in Scheme 10, the employment of alkynyl-
4,5-secocholestan-5-ol 33 in such a metal-catalyzed MCR led to
the steroidal chroman-ketal 34 as a mixture of epimers at the
center bearing the methoxy group, instead of the expected
chroman spiroketal. The authors proposed the initial formation
of a 6-membered enol ether, which may subsequently undergo
either a stepwise Pd(II)-catalyzed cascade process or a [4 + 2]
cycloaddition reaction, both providing the cis stereochemistry at
C-2 and C-3. When the reaction was carried out with the epimer
of substrate 33 (having the 5β-hydroxy group), the cis stereo-
chemistry was also achieved at the newly formed C-2 and C-3,
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Scheme 10: Pd(II)-catalyzed three-component reaction with an alkynyl seco-cholestane [34].
Scheme 11: Multicomponent synthesis of steroid–thiazole hybrids from a steroidal ketone [36].
but with the tetrahydropyrane ring having α orientation. A mix-
ture of epimers at position 4' was also obtained when using the
C-5 epimer of substrate 33.
Asif et al. [36] developed another 3CR for the synthesis of
steroidal thiazole derivatives. As shown in Scheme 11,
cholestanic ketone 7 was reacted with a thiosemicarbazide and
2-bromo-1-phenylethan-1-one under microwave irradiation to
form the steroid–thiazole hybrid 35 in very good yield. As pre-
viously mentioned, due to the poor reactivity of steroidal ke-
tones and their imine derivatives, most MCRs with ketosteroids
described in the literature required a high temperature set by
classic heating or microwave irradiation.
Using cholic acid as carboxylic acid component, Cui and
co-workers [37] developed a novel MCR resembling the Ugi-
4CR, but relying on the reactivity of ynamides as surrogates of
the isocyanide component. Ynamides are alkynes with a car-
bon–carbon triple bond attached to a nitrogen atom that gives
them both nucleophilic and electrophilic properties. This dual
reactivity is similar to that shown by isocyanides, as they may
react with iminium ions and carboxylates as isocyanides do.
However, in comparison with the typical Ugi-4CR where the
isocyanide component acts as a one-carbon center, in this reac-
tion the ynamide compound has a two-carbon center role. As
shown in Scheme 12, the reaction of dehydrocholic acid (36),
an amine and an aldehyde with the key ynamide component
provided a new type of pseudo-peptidic steroid 37, obtained as
a 1:1 mixture of diastereomers. Besides steroids, the authors
proved that a wide variety of components participate in this
reaction, unfortunately always rendering mixtures of diastereo-
mers when pro-chiral aldehydes were employed [37]. Also dif-
ferently from the Ugi-4CR, this MCR requires the use of a
Lewis acid like BF3·Et2O for a suitable activation of the imine.
Beilstein J. Org. Chem. 2019, 15, 1236–1256.
1246
Scheme 12: Synthesis of cholanic pseudo-peptide derivatives by novel MCRs based on the reactivity of ynamide [37,38].
Based on the same idea of exploiting the reactivity of ynamides,
Cui’s group developed a 3CR wherein an o-hydroxy-
benzhydryl alcohol was used in place of the aldehyde or imine
components upon reaction with ynamide and a carboxylic acid
[38]. Scheme 12 depicts the implementation of this 3CR with
dehydrocholic acid 36 to furnish steroid derivative 38 functio-
nalized at the side chain. This reaction incorporated an ester
group at the position where the analogous 4CR created a tertiary
amide, because of the similarities between the Passerini and Ugi
reactions.
3 Synthesis of steroid-fused heterocycles
The modification of the steroidal nucleus by attaching a hetero-
cycle to this hydrophobic scaffold has been traditionally used as
an effective way to modulate the biological activity of these
biomolecules. In this regard, pentacyclic steroids are a class of
pharmacologically relevant steroid derivatives in which the
steroid-ring system has a fused heterocyclic or carbocyclic ring.
The fifth ring is typically fused to the steroid on ring A, B or D
and some times more than one ring is fused, thus generating
hexacyclic or heptacyclic steroids. To our knowledge, there are
no reports of fused heterocyclic or carbocyclic rings on the ring
C of the steroid. In this section, we discuss different reports on
the synthesis of steroid-fused heterocycle using MCRs.
Wang et al. [39] developed a synthetic route based on the
Biginelli reaction for the preparation of steroidal derivatives
with a pyrimidine moiety fused to ring D. This heterocycle
moiety appears in different biologically active steroids fused to
ring D, and previous non-MCR methods had been reported for
the creation of libraries of such hybrid compounds [40]. The
Biginelli reaction reported in 1893 comprises the acid–cata-
lyzed condensation of ethyl acetoacetate, benzaldehyde and
urea to generate 3,4-dihydropyrimidin-2(1H)-one [41]. From
that time, the reaction was extended to Lewis-acid catalysis and
the use of other solvents such as methanol or aprotic solvents
such as THF, dioxane, acetonitrile, etc. Because the reaction
rate is slow at room temperature, it needs activation by heating
or other non-traditional methods such as ultrasound, micro-
wave, IR irradiation and photochemical irradiation, as it will be
exemplified below.
In terms of reactants, the reaction seems to work best using aro-
matic aldehydes with both electron-withdrawing and donating
substituents in ortho, meta and para-positions. In addition, not
only acetoacetates can be employed, but the reaction can be ex-
tended to ketones, thioesters, benzoylacetic esters, acetoac-
etamides, alkylic or cyclic β-diketones, etc. The urea compo-
nent has the main structural restrictions, since monosubstituted
alkyl ureas work well but thioureas have provided much lower
yields. Wang et al. produced a library of steroidal [17,16-
d]pyrimidine derivatives such as 40 employing a particular
extension of the Biginelli reaction based on the use of 17-keto-
steroids and chlorotrimethylsilane (TMSCl) as catalyst, which
enables the formation of the nucleophilic enolate that attacks
either benzaldehyde or its urea imine derivative [39]. Varied
ketosteroids were employed, including methylestrone 39, dehy-
droepiandrosterone acetate and epiandrosterone acetate, etc., all
providing excellent yields of steroidal pyrimidines after 12 h of
reaction at 90 °C (Scheme 13). The reaction sequence of this
multicomponent protocol comprises the initial formation of the
Biginelli product, followed by aromatization under air to
furnish the heterocyclic ring fused at positions 16 and 17.
In a recent report, Baji et al. [42] utilized a modified Biginelli-
3CR between ketosteroid 41, urea and different benzaldehyde
derivatives for the synthesis of steroid ring A-fused pyrimidi-
nones 42. In this case, the heterocyclic ring was produced by a
second step using the strong oxidizing Jones reagent, because
the oxidizing power of sulfuric acid was not enough to achieve
oxidation. Interestingly, the use of microwave irradiation
instead of classic heating allowed obtaining the Biginelli prod-
uct in only 10 min, instead of 12 h as required for the synthesis
of pyrimidines 40 (Scheme 13).
An alternative setup of Biginelli-3CR with steroids was re-
ported by Boruah and co-workers [43] using ultrasound assis-
tance instead of microwave irradiation or thermal heating. In
Beilstein J. Org. Chem. 2019, 15, 1236–1256.
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Scheme 13: Synthesis of steroid-fused pyrimidines and pyrimidones using the Biginelli-3CR [39,42,43].
this case, the reaction between cholestanic ketone 43, an alkyl
or arylaldehyde, and urea or thiourea could be conducted under
ultrasound irradiation using sodium ethoxide as catalyst, thus
generating steroid ring A-fused 3,4-dihydropyrimidinones and
3,4-dihydropyrimidinthiones 44 in very good yields.
Mohamed et al. [44] reported a 4CR for the synthesis of pyri-
dopyrimidines fused to ring D of androstanic steroids. Such
heterocyclic moieties are of interest because of their pharmaco-
logical activity, for example, as anti-inflammatory agents. Em-
ploying epiandrosterone and benzaldehyde as oxo components,
ammonium acetate and malononitrile as C-nucleophile, the
authors produced 2-amino-3-cyano-1,4-dihydropyridine 46
fused to the androstane at positions 16 and 17 (Scheme 14). The
MCR proceeds by the condensation of malononitrile with
benzaldehyde to form the benzylidene malononitrile adduct, and
of the ketosteroid with ammonium to form the steroidal en-
amine, which cyclizes with the benzylidene to furnish the 1,4-
dihydropyridine scaffold. As depicted in Scheme 14, com-
pound 46 was later subjected to a variety of post-MCR cycliza-
tions, including the reaction with carboxylic acids to form the
fused steroidal pyridopyrimidinones 47 and with carbon disul-
fide to form pyridopyrimidinedithione 48 in very good yields.
Overall, five different components are incorporated in the reac-
tion sequence, whereas acid chlorides, anhydrides, hydrazine,
etc., could also be employed in the post-MCR cyclization [44].
The library of steroidal heterocycles was tested against oxida-
tive stress and neuroinflammation due to cerebral injection of
lipopolysaccharide endotoxin, with some compounds showing
antioxidant and antineuroinflammatory activities. The same
group employed this 4CR with cholestan-3-one for the con-
struction of 2-amino-3-cyanodihydropyridine scaffold fused to
ring A of the cholestane system [45].
Also targeting steroid-fused pyrimidines, Boruah’s group de-
veloped a solid-phase MCR between 2-hydroxymethylene-3-
ketosteroids, aromatic aldehydes and ammonium acetate [46].
As shown in Scheme 15, the reaction was carried out with
steroid 49 and different aldehydes to furnish the set of com-
pounds 50 in good to excellent yields. The proposed mecha-
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Scheme 14: Synthesis of steroidal pyridopyrimidines by a reaction sequence comprising a 4CR followed by a post-MCR cyclization [44].
Scheme 15: Synthesis of steroid-fused pyrimidines by MCR of 2-hydroxymethylene-3-ketosteroids [46].
nism begins with the formation of the β-aminoketoimine by
condensation of the steroid with two molecules of ammonia,
followed by the reaction with arylaldehyde and intramolecular
cyclization to a dihydropyrimidine skeleton, which suffers oxi-
dation to the aromatic heterocyclic ring
Boruah and co-workers extended the same approach to differ-
ent steroidal starting materials and varied the substituents in the
arylaldehyde component to investigate the steric and electronic
effects on the yields of the steroid-fused pyrimidine products
[43]. Thus, the yield increases when the substituent of the
arylaldehyde is in para-position, but decrease with the substitu-
ent in ortho-position, likely due to steric hindrance that limits
the cyclization process. In terms of electronic effect, electron-
withdrawing groups (e.g., F, Cl, Br, NO2) favor the heterocycli-
zation, but electron-donating groups like CH3 and OMe does
only partially. Both steric and electronic effects can be ex-
plained from the reactivity of the diimine intermediate. An elec-
tron-withdrawing group promotes the nucleophilic attack of the
ketoimine N by increasing the partially positive charge of the
imine C. In general, Boruah’s group has been very active in the
synthesis of nitrogen heterocycles such as pyrimidines, pyra-
zolopyrimidines and disubstituted pyridines fused to rings A
and D of steroids [47-49].
Thus far, most applications of MCRs in steroid derivatization
aimed at producing derivatives for screening their biological
and pharmacological properties. A different example is the
utilization of MCR-derived steroids as analytical patterns of
petroleum samples. Steroids are present as “biomarker” compo-
nents of petroleum, fused with asphaltenes, which are struc-
turally complex molecules with polycyclic aromatic or partially
aromatic hydrocarbons, heteroatoms, alkyl chains and polar
functions. As asphaltenes, such steroid-asphaltene derivatives
are constituents of the heaviest fractions of petroleum. Under-
standing the physical characteristics of these derivatives allows
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1249
Scheme 16: Synthesis of steroid-fused naphthoquinolines by the Kozlov–Wang MCR using ketosteroids [50,51].
their removal from the heavy oil fractions; such compounds are
too complex for analysis at a molecular level, so it is important
to synthesize analytical standards for their study.
In this context, Schulze et al. optimized a multicomponent
cyclocondensation reaction [50,51] between 5α-cholestan-3-one
(43), aromatic aldehydes and 2-aminoanthracene (51) for the
generation of steroidal naphthoquinolines as synthetic asphal-
tene models for the study of their physical properties. As shown
in Scheme 16, the synthetic approach was based on
Kozlov–Wang MCR [52], in which an aromatic aldehyde,
2-aminoanthracene and tetrahydropyran-4-one react in the pres-
ence of I2 as catalyst. The mechanism follows the initial forma-
tion of the imine compound between the aldehyde and the
arylamine, followed by an imino-Diels–Alder reaction with the
enolate generated from the ketosteroid. The reaction is highly
regioselective for the enolization of the ketone, thus giving the
ring A-fused pyridine at positions 2 and 3. This iodine-
promoted MCR tolerates both electron-donating and electron-
withdrawing groups on the aromatic aldehyde, thus leading to
varied, optically active asphaltene model compounds that could
serve as structural mimetics of known components of heavy
oils.
Besides the fusion of the steroidal nucleus to heterocycles by
MCRs, there is a whole field of research developed by Tietze
and co-workers in the 90’s dealing with the construction of
heterosteroids, D-homosteroids (steroids with all 6-membered
rings) and azasteroids (steroids with a nitrogen atom in their
nucleus) [53,54]. This strategy employs domino Knoevenagel/
hetero-Diels–Alder procedures for the assembly of such steroid
mimics. However, we have decided not to include it in this
review because several book chapters and reviews have already
covered this chemistry [55,56].
4 Conjugation of steroids to carbohydrates
and peptides
The conjugation of steroids to other biomolecules such as
carbohydrates and peptides represents a valuable strategy for
providing new properties to the hydrophobic steroid skeleton.
Naturally occurring steroid–sugar conjugates such as saponins
have shown to possess physicochemical and biological features
different from those of the two separate molecular entities
[57,58]. Despite nature does not provide examples of
steroid–peptide conjugates, chemists have produced such conju-
gates to be employed as protease-like artificial enzymes [59] as
mimics of the natural cationic peptide antibiotics [60] or as a
way to constrain peptide sequences in protein epitope confor-
mations [61]. In this regard, the groups of Rivera and Wessjo-
hann have pioneered the utilization of MCRs for the conjuga-
tion of oligosaccharides [62] and peptides [63,64] to steroids,
thus producing unique types of steroidal conjugates.
Scheme 17 depicts the strategy toward steroidal conjugates
using the Ugi-4CR, which allows accessing a high level of
diversity by varying the combinations of the carbohydrate,
peptide and steroidal functional groups reacting on the multi-
component conjugation [62,63]. Cytotoxic spirostan saponins
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Scheme 17: Conjugation of steroids to carbohydrates and peptides by the Ugi-4CR [62,63].
were chosen as model compounds for the preparation of Ugi-
derived analogues, such as 55 and 56 suitable for biological
evaluation [62]. Besides the glucose unit, other trisaccharidic
moieties (e.g., β-chacotrioside) could also be conjugated to
functionalized spirostanic steroids by Ugi-type MCRs.
In addition, Rivera, Wessjohann and co-workers [63] extended
the concept of the Ugi conjugation strategy to a distinctive
family of peptide–steroid conjugate having the steroid skeleton
or the side chain attached to the peptide backbone as internal
N-substituent. As shown in Scheme 17, amino steroids could be
reacted in MeOH or MeOH/CH2Cl2 at room temperature with
peptide carboxylic acids and isocyanopeptides to furnish
peptide–steroid conjugates such as 58 and 59. Interestingly, the
same solution-phase protocol proved to be equally effective for
the conjugation of two different steroidal scaffolds [65], but it
failed for the ligation of larger peptides to steroids due to the
poor solubility of the former ones.
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Scheme 18: Solid-phase multicomponent conjugation of peptides to steroids by the Ugi-4CR [64].
Scheme 19: Solid-phase multicomponent conjugation of peptides to steroids by the Petasis-3CR [68].
In this sense, Rivera’s group introduced a solid-phase multi-
component procedure enabling the conjugation of steroids and
lipids to peptides longer than 10 amino acid residues [64]. As
shown in Scheme 18, the procedure comprised the growth of
the antimicrobial peptide sequence 60 followed by the multi-
component incorporation of cholestanic steroids functionalized
as isocyanide component. Two related on-resin Ugi-4CRs were
employed, i.e., the Ugi-azide reaction based on hydrazoic acid
as acid component that furnished peptide-steroid 61 and the
classic one using acetic acid as carboxylic acid component,
which led to conjugate 62. These protocols enabled the intro-
duction not only of a steroidal moiety at the N-terminus but also
of lipid and affinity tags (e.g., biotin) [64]. Importantly, the
effective implementation of on-resin Ugi-4CRs paved the way
for the subsequent development of multicomponent macrocy-
clizations permitting the introduction of PEGs, sugars and fluo-
rescent labels at resin-linked peptides [66,67].
More recently, Wessjohann and Rivera [68] increased the diver-
sity of MCRs that can be used to ligate peptides to steroids with
the development of a novel multicomponent conjugation
process based on the Petasis-3CR. The Petasis reaction [69] also
known as the borono-Mannich reaction, is a MCR comprising
the condensation of an aldehyde or ketone, an amine and an
aryl/vinylboronic acid or ester. As illustrated in Scheme 19, the
on-resin implementation of this reaction allowed, for the first
time, the ligation of oligopeptides to biologically relevant
steroids. Thus, resin-linked peptides 63 and 66 could be ligated
either by Lys side chains or by the N-terminus to the estrone-
derived boronic acid 64 using the on-resin Petasis-3CR in the
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presence of dihydroxyacetone [68]. Peptido-steroids 65 and 67
were obtained in good overall yields after released from the
resin using the cocktail TFA/H2O/triisopropylsilane (TIS),
albeit the conjugation at the N-terminus required microwave ir-
radiation due to the bulkier character of the amino component.
Besides steroids, the method worked well with varied boronic
acids, including those bearing fluorescent labels, lipids and PEG
chains, thus providing a new class of biomolecular conjugates
showing promise for the future development of peptide pharma-
ceuticals.
5 Multicomponent synthesis of steroidal
macrocycles and cages
Since the beginning of this century, the field of macrocycle syn-
thesis has witnessed the emergence of MCRs as effective ring
closing procedures, including the cyclization of large scaffolds
containing the rigid steroid skeleton. In this regard, Wessjo-
hann can be considered as the pioneer of the synthesis of
steroidal macrocycles using MCRs [12,13] including remark-
able examples of huge macrocycles formed by the condensa-
tion of up to twelve components. Whereas the reports up to
2008 have been included in previous reviews [12,13] this
section will cover those reports from 2009 on, with emphasis on
multicomponent macrocyclization approaches leading to
steroidal cages.
The first report of a MCR-derived steroidal macrocycles was
described by Wessjohann et al. in 2005 as part of a synthetic
program towards steroid-based supramolecular receptors [28].
There, steroidal diamines and diisocyanides derived from bile
acids were employed in a procedure known as MiBs, i.e.,
multiple multicomponent macrocyclization including bifunc-
tional building blocks. In a series of subsequent reports,
Wessjohann’s group exploited the MiBs strategy based on the
Ugi-4CR for the assembly of topologically diverse steroidal
macrocycles incorporating a variety of (seco)steroid skeletons
[70-72].
Probably the highest level of macrocycle complexity achieved
in one-pot can be found in the multicomponent synthesis of
steroidal cages multiple multicomponent macrocyclization [73].
As shown in Scheme 20, Rivera and Wessjohann expanded the
MiBs concept to the development of a threefold Ugi-4CR-based
macrocyclization between cholanic tricarboxlic acid 68 and an
aliphatic triisocyanide in the presence of three equivalents each
of paraformaldehyde and isoprolylamine to furnish steroidal
cage 69 in good yield. This multicomponent macrocyclization
approach was implemented by setting up pseudo-dilution condi-
tions [74], i.e., the simultaneous slow addition of two trifunc-
tional components with syringe pumps to a stirring solution of
the pre-formed imine (3 equiv), which avoids formation of
higher oligomers. Remarkably, such procedure was undertaken
with formation of twelve covalent bonds and the incorporation
of eight components in one pot. A few years later, the same
authors described the implementation of a sequential MiBs
strategy for the construction on hybrid macromulticycles in-
cluding a steroidal skeleton as one of the tethers [75].
Scheme 20 illustrates one of the examples reported by Wessjo-
hann’s group, in which cholanic dicarboxylic acid 70 was sub-
jected to an initial macrocyclization based on two Ugi-4CRs
with a biaryl ether diisocyanide and two equivalents of para-
formaldehyde and a monoprotected diamine. After the initial
macrocyclization, steroidal macrocycle 71 was deprotected by
removal of the Cbz groups and subsequently submitted to a
second multicomponent macrocyclization protocol – in this case
serving as diamino component – to render macrobicycle 72 in
moderate yield over three steps. Despite the process was not
conducted in one pot, this simple synthetic setup was employed
to produce a set of very complex steroidal macrobicycles suit-
able for molecular and ion pair encapsulation [75].
Aiming at producing a more efficient and straightforward
method toward macrobicycles, Wessjohann and Rivera [76]
implemented a double Ugi-4CR-based macrocyclization com-
prising the one-pot assembly of three different bifunctional
building blocks, one of them of steroidal nature. Differently
from any other MiBs approach, this procedure focuses on con-
structing the macrobicycle connectivity by the bridgeheads
instead of the tethers, which are brought together by the two
Ugi-4CRs. As shown in Scheme 21, this method allows the
assembly of hybrid steroidal cages with the incorporation of
three bifunctional components. Thus, cholanic dicarboxylic
acids 73 and 74 were macrocyclized with a paraformaldehyde-
derived diimine and two different aryl diisocyanides to furnish
steroidal cages 75 and 76 in good yields considering the struc-
tural complexity created in a single synthetic operation. It is
worth mentioning that due to the rigid nature of the steroidal
and aryl components, a flexible diamine was required to facili-
tate the macrobicycle ring closure. As before, pseudo-dilution
conditions were employed by the simultaneous slow addition of
the three bifunctional components.
Conclusion
We have demonstrated that MCRs are powerful tools for the
derivatization of steroids, including the formation of steroidal
heterocycles and macrocycles and the conjugation to other bio-
molecular components. Various well-known MCRs such as the
Ugi, Passerini, Biginelli and Petasis reactions have proven
effective in the installation of skeletal diversity attached to the
steroid ring system, while many other modern methods have
also shown success using steroidal as one of their components.
In addition, we showed that the synthesis of steroid–peptide and
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Scheme 20: Synthesis of steroidal macrobicycles (cages) by multiple multicomponent macrocyclizations based on the Ugi-4CR [73,75].
Scheme 21: One-pot synthesis of steroidal cages by double Ugi-4CR-based macrocyclizations [76].
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steroid–carbohydrate conjugates is feasible by means of both
solution and solid-phase multicomponent methodologies, which
opens a venue of possibilities for the production of more com-
plex biomolecular conjugates. Nonetheless, there are still many
MCRs that have not been implemented using steroidal sub-
strates, therefore, there is still much to be done for an effective
exploitation of the MCR potential in the rapid diversification of
steroidal products for screening of their pharmaceutical and bio-
logical properties. We expect this review serves as inspiration
for the MCR community to further explore the scope of steroids
in the development of new reactions and methods.
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